NLSP   $2.32  -3.73% Market Closed After Close 2.1901 -5.60%

NLS Pharmaceutics AG
Total Cash 552.76K
totalCashPerShare 0.561
EBITDA -6.30M
Total Debt 1.71M
quickRatio 0.082
currentRatio 0.155
Total Revenue
debtToEquity
Revenue/Share
ROA -2.27764
ROE
grossProfits
freeCashflow -1.85M
operatingCashflow -3.92M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 5.19M
forwardPE
floatShares 748.48K
sharesOutstanding 3.82M
sharesShort 51.75K
sharesShortPriorMonth 31.25K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.28%
heldPercentInstitutions 0.15%
Short Ratio help_outline 1.64%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue -9.402
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -6.60M
trailingEps -6.82%
forwardEps -0.55%
enterpriseToEbitda -0.82
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 11
lastUpdated Nov. 7, 2024, 4:53 a.m.